The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.

Also called NCT01423188

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 176 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01423188
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Africa (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01423188. Randomized; triple masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2012-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation
Acronym
SUSTAIN
Condition
Dyslipidemia
Intervention (Drug)
RVX000222
Intervention (Drug)
Placebo RVX000222
Lead sponsor
Resverlogix Corp (class: industry)
Collaborator
The Cleveland Clinic (class: other)

Record details

Record id
cardio:ct-nct01423188
Content hash
78fa5340a879f0f79fe1b0ebf2b74bb730fbc5971fbd7b7e88729655f85ff89f